GPT and metabolic dysfunction-associated steatotic liver disease: Increased ALT and AST in obese individuals is usually a marker of NAFLD, an early stage of the liver disorder which can progress to nonalcoholic steatohepatitis (NASH) or even liver cirrhosis [15].